ATE441437T1 - Verfahren zur identifizierung von respondern auf die behandlung mti insulinsensibilisatoren - Google Patents

Verfahren zur identifizierung von respondern auf die behandlung mti insulinsensibilisatoren

Info

Publication number
ATE441437T1
ATE441437T1 AT04810280T AT04810280T ATE441437T1 AT E441437 T1 ATE441437 T1 AT E441437T1 AT 04810280 T AT04810280 T AT 04810280T AT 04810280 T AT04810280 T AT 04810280T AT E441437 T1 ATE441437 T1 AT E441437T1
Authority
AT
Austria
Prior art keywords
adiponectin
amount
therapeutic treatment
patient
mti
Prior art date
Application number
AT04810280T
Other languages
English (en)
Inventor
John Wagner
Philipp Scherer
Utpal Pajvani
Original Assignee
Merck & Co Inc
Einstein Coll Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc, Einstein Coll Med filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE441437T1 publication Critical patent/ATE441437T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/0004Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders
    • G01N2800/042Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT04810280T 2003-11-07 2004-11-04 Verfahren zur identifizierung von respondern auf die behandlung mti insulinsensibilisatoren ATE441437T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51839003P 2003-11-07 2003-11-07
PCT/US2004/036648 WO2005046734A1 (en) 2003-11-07 2004-11-04 Method of identifying responders to treatment with insulin sensitizers

Publications (1)

Publication Number Publication Date
ATE441437T1 true ATE441437T1 (de) 2009-09-15

Family

ID=34590257

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04810280T ATE441437T1 (de) 2003-11-07 2004-11-04 Verfahren zur identifizierung von respondern auf die behandlung mti insulinsensibilisatoren

Country Status (10)

Country Link
US (1) US20070098636A1 (de)
EP (1) EP1684807B1 (de)
JP (1) JP4397934B2 (de)
CN (1) CN1882363A (de)
AT (1) ATE441437T1 (de)
AU (1) AU2004289237C1 (de)
BR (1) BRPI0416248A (de)
CA (1) CA2545065C (de)
DE (1) DE602004022968D1 (de)
WO (1) WO2005046734A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008273938A (ja) * 2007-03-30 2008-11-13 Shiseido Co Ltd アディポネクチン産生促進剤
WO2008156617A2 (en) * 2007-06-15 2008-12-24 Smithkline Beecham Corporation Methods and kits for predicting treatment response in type ii diabetes mellitus patients
US20080312154A1 (en) * 2007-06-15 2008-12-18 Barbara Lee Peterlin Administration of adipocytokine and adiponectin for treating headache and methods of diagnosing headache by measuring adiponectin
CN101932728B (zh) 2007-11-30 2013-06-19 西门子医疗保健诊断公司 脂连蛋白受体片段和使用方法
WO2010123720A1 (en) 2009-04-23 2010-10-28 Siemens Healthcare Diagnostics Inc. Monomeric and dimeric forms of adiponectin receptor fragments and methods of use
AU2009325962A1 (en) * 2008-12-11 2011-07-28 Ikfe Institut Fur Klinische Forschung Und Entwicklung Gmbh Biomarkers for insulin sensitizer drug response
EP2382467A1 (de) * 2008-12-30 2011-11-02 IKFE GmbH Biomarker für fettgewebeaktivität
JP7116413B2 (ja) * 2018-03-02 2022-08-10 株式会社山田養蜂場本社 選別方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1426764T3 (da) 2001-08-17 2011-06-27 Fujirebio Kk Fremgangsmåde til diagnosticering eller monitorering af fejl i sukkermetabolisme
JP4677545B2 (ja) * 2003-10-15 2011-04-27 積水メディカル株式会社 多量体アディポネクチンの分別測定方法

Also Published As

Publication number Publication date
AU2004289237A1 (en) 2005-05-26
AU2004289237C1 (en) 2009-02-26
EP1684807A4 (de) 2008-03-19
JP2007510906A (ja) 2007-04-26
EP1684807A1 (de) 2006-08-02
JP4397934B2 (ja) 2010-01-13
WO2005046734A1 (en) 2005-05-26
AU2004289237B2 (en) 2008-08-21
BRPI0416248A (pt) 2007-01-09
CA2545065A1 (en) 2005-05-26
US20070098636A1 (en) 2007-05-03
CA2545065C (en) 2012-07-17
EP1684807B1 (de) 2009-09-02
DE602004022968D1 (de) 2009-10-15
CN1882363A (zh) 2006-12-20

Similar Documents

Publication Publication Date Title
Walker et al. Leucine competes with kynurenine for blood-to-brain transport and prevents lipopolysaccharide-induced depression-like behavior in mice
Takeuchi et al. The prevalence of frailty and its associated factors in Japanese hemodialysis patients
Newgard et al. Revisiting the “golden hour”: an evaluation of out-of-hospital time in shock and traumatic brain injury
Ansell et al. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidence-based clinical practice guidelines
Ordonez et al. Aerobic training improved low‐grade inflammation in obese women with intellectual disability
Plowman Is there a role for exercise in the management of bulbar dysfunction in amyotrophic lateral sclerosis?
Meesters et al. The effect of Mindfulness-Based Stress Reduction on wound healing: a preliminary study
Ventä et al. Oral piercings among first-year university students
ATE441437T1 (de) Verfahren zur identifizierung von respondern auf die behandlung mti insulinsensibilisatoren
Stener-Victorin et al. Effects of acupuncture and exercise on insulin sensitivity, adipose tissue characteristics, and markers of coagulation and fibrinolysis in women with polycystic ovary syndrome: secondary analyses of a randomized controlled trial
DE69230000D1 (de) Verfahren und testsatz zur messung von endogenen zytokinen
AI-Khawaja et al. The Barthel Index and its relationship to nursing dependency in rehabilitation
Khanum et al. Effects of diaphragmatic breathing exercises on blood sugar levels in working class females with type-2 diabetes mellitus
Burton The external examination: An often-neglected autopsy component
Rosyanti et al. The Effectiveness of Complementary" Cupping Therapy" On The Community's Routine Blood Hematology Status During The COVID-19 Pandemic
DE502004012230D1 (de) Verfahren zur diagnose von erkrankungen unter bestimmung von apolipoprotein c-i
Ilkafah et al. Analysis of Factors Related to Self Management Behavior (SMB) in Hypertensive Patients
Özkaptan et al. Attitudes of nursing students towards older people in Turkey
Sharma Patient Satisfaction and Oral Health-related Quality of Life (ohrqol) of Edentulous People after Mandibular Denture Relining With a Soft-liner Material: A Pilot Study
Spasovska Trajanovska et al. Plasma cortisol levels in heroin addicts
Van Hattum Health strategy on HCV in The Netherlands
Batool Factors Responsible for Tooth Extraction Among Patients of Dental Disease
Amsler et al. OP0149 VISUAL LOSS IN PATIENTS WITH GIANT CELL ARTERITIS TREATED WITH TOCILIZUMAB
Moore et al. Fear 0finjectionSand fep0t0f negative dentiSt behaV0fam0ng CaUC3Sian
Head DISEASES

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties